Vanberra Signal

KeyBio

Curated by Signal

Provider of a platform for therapeutic and biomarker discovery

Overview

Provider of a platform for therapeutic and biomarker discovery. It Identify pathways that drive molecular subtypes of disease progression and predicting survival than tumor multi-omics. It also optimize clinical trials for safety and efficacy with patient selection strategies.

Key facts

Founded
2023

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provides smart devices and app-based solution for managing diabetes

    Health TechnologyMinneapolis, United States
  • Wearable solution to detect musculoskeletal disorders using pressure sensing insoles

    Health TechnologySeattle, United States
  • Provider of cannabis-derived supplements and wellness products

    Health TechnologyBoulder, United States

About KeyBio

What does KeyBio do?

Provider of a platform for therapeutic and biomarker discovery.

Where is KeyBio headquartered?

KeyBio is headquartered in Cambridge, United States.

When was KeyBio founded?

KeyBio was founded in 2023.

Which sector is KeyBio in?

KeyBio operates in Health Technology.

Who are KeyBio's competitors?

Companies similar to KeyBio include Pops Diabetes, JumpStart, and Moon Mother Hemp.